RHO.F Roche Holding AG

Healthcare Pharmaceuticals Frankfurt Exchange
3,338 EUR
Close of Nov 13, 2026
300.53 449.00
Market cap
EUR 356B
P/E
27.0x
P/B
9.98x
ROE
38.1%
Dividend yield
2.44%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is RHO.F undervalued?

Graham number

The Graham number of Roche Holding AG cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Roche Holding AG fundamental analysis

No fundamental analysis for Roche Holding AG yet.

Roche Holding AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various dise…

Full company profile